Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-26 @ 3:16 AM
Study NCT ID:
NCT04523220
Status:
COMPLETED
Last Update Posted:
2023-07-21
First Post:
2020-08-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-20
First Submit QC Date:
None
Study First Post Date:
2020-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-05
Results First Submit QC Date:
None
Results First Post Date:
2023-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-07-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-07-13
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL